CG
RVNC

Cutler Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Cutler Group’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,600
Closed -$1K – 4892
2022
Q4 		$1K Sell
4,600
-19,400
-81% -$444K ﹤0.01% 4212
2022
Q3 		$110K Buy
24,000
+6,000
+33% +$122K 0.01% 1334
2022
Q2 		$22K Buy
18,000
+7,600
+73% +$117K ﹤0.01% 2610
2022
Q1 		$40K Buy
10,400
+9,800
+1,633% +$149K ﹤0.01% 2448
2021
Q4 		$2K Buy
+600
New +$10K ﹤0.01% 4870
2021
Q1 		– Sell
-1,500
Closed -$1K – 6448
2020
Q4 		$1K Buy
+1,500
New +$38.9K ﹤0.01% 4641
2018
Q1 		– Sell
-1,500
Closed -$8K – 5384
2017
Q4 		$8K Buy
1,500
+100
+7% +$2.87K ﹤0.01% 3327
2017
Q3 		$6K Buy
1,400
+600
+75% +$14.5K ﹤0.01% 4279
2017
Q2 		$4K Sell
800
-1,000
-56% -$22.3K ﹤0.01% 5110
2017
Q1 		$7K Sell
1,800
-20,900
-92% -$429K ﹤0.01% 4445
2016
Q4 		$14K Sell
22,700
-40,300
-64% -$675K ﹤0.01% 3861
2016
Q3 		$14K Sell
63,000
-8,900
-12% -$129K ﹤0.01% 3833
2016
Q2 		$23K Buy
71,900
+68,900
+2,297% +$1.22M ﹤0.01% 3219
2016
Q1 		$5K Sell
3,000
-1,900
-39% -$38.7K ﹤0.01% 4906
2015
Q4 		$9K Buy
+4,900
New +$170K ﹤0.01% 4300

Other funds holding RVNC

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cutler Group's RVNC Position: Q1 2023 in Review

Cutler Group sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2023, closing a stake of 4,760 shares — an estimated $87K sold.

Cutler Group first reported a position in RVNC in Q4 2015 and held it in 20 quarters. The position peaked at $230K in Q4 2015. 216 funds tracked by Wall St. Rank hold RVNC as of Q1 2023.

  • Cutler Group reported no remaining Revance Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 4,760 Revance Therapeutics, Inc. shares in Q1 2023, an estimated $87K.
  • Cutler Group first reported a position in Revance Therapeutics, Inc. in Q4 2015 and held it in 20 quarters.
  • Cutler Group's Revance Therapeutics, Inc. position peaked at $230K in Q4 2015.
  • 216 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.